Lackner Mark
SEC CIK 1777413 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | CSO | 527.2K | — | $56.6K | 6 | 2024-01-02 | 2025-02-03 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Lackner Mark made no open-market trades at ZNTL in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Lackner Mark | CSO | A - Grant | $0.00 | +335.9K | 527.2K | +176% | $0 |
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Lackner Mark | CSO | S - Sale | $1.71 | -14.4K | 512.9K | -3% | -$24.6K |
| 2025-01-03 | 2025-01-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Lackner Mark | CSO | S - Sale | $3.12 | -4,411 | 191.3K | -2% | -$13.8K | |
| D | 2024-02-05 | 2024-02-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Lackner Mark | CSO | S - Sale | $11.54 | -1,585 | 195.7K | -0.8% | -$18.3K |
| D | 2024-02-05 | 2024-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Lackner Mark | CSO | A - Grant | $0.00 | +141.0K | 197.3K | +250% | $0 |
| D | 2024-01-03 | 2024-01-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Lackner Mark | CSO | A - Grant | $0.00 | +40.0K | 56.3K | +245% | $0 |
Purchase Sale Sale after option exercise All abbreviations